Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 1/2008

01-02-2008

Utilization of dietary vitamin K supplementation to aid in INR stabilization for patients on chronic oral anticoagulant therapy: a series of case reports

Authors: L. Earl, R. Pena, J. Hutchinson

Published in: Journal of Thrombosis and Thrombolysis | Issue 1/2008

Login to get access

Excerpt

Warfarin is a narrow therapeutic range medication with numerous potential factors affecting its’ metabolism with consequent fluctuation of the International Normalized Ratio (INR) outside of the therapeutic range. Identifying factors that can be managed by the patient to aid in stabilization of the INR is a key goal of anticoagulation management. In patients who report stable medication usage (both prescription and over-the-counter), dietary intake of vitamin K rich foods, alcohol intake, and stable use of vitamin and herbal preparation supplementation, but who continue to have unstable INRs, the use of vitamin K supplementation has been shown to afford some stabilization of INRs. In each of our practices, from three different settings (a university hospital, a large health maintenance organization and a small rural hospital anticoagulation management service), dietary grade vitamin K supplementation, in doses ranging from 100 to 300 micrograms daily, has been instituted in a small cohort of patients in an effort to achieve INR stabilization. Each patient is on chronic anticoagulation with warfarin and other possibilities of INR fluctuations (co-morbidities, medication changes, compliance, dietary changes, and alcohol ingestion) have been explored as possible contributing factors for unstable INRs. Upon initiation of dietary vitamin K, improvement in INR stabilization did not occur in most cases. Increases in warfarin dose requirements occurred in most cases. Further studies in the use of dietary vitamin K to aid in INR stabilization are required before such adjunct therapy can be broadly recommended. …
Metadata
Title
Utilization of dietary vitamin K supplementation to aid in INR stabilization for patients on chronic oral anticoagulant therapy: a series of case reports
Authors
L. Earl
R. Pena
J. Hutchinson
Publication date
01-02-2008
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 1/2008
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-007-0112-y

Other articles of this Issue 1/2008

Journal of Thrombosis and Thrombolysis 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.